Research confirms Care222® far UV-C efficacy against original SARS-CoV-2 and variant
Hiroshima University and Ushio Inc. research showed Care222 technology is equally effective in inactivating a SARS-CoV-2 variant as in inactivating the original SARS-CoV-2 strain.